Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Analysis of Gene Expression and Neuronal Phenotype in Neuroscreen-1 (NS-1) Cells.

Pokharel S, Lee CH, Gilyazova N, Ibeanu GC.

Int J Biomed Investig. 2018 Sep-Dec;1(3). pii: 115. Epub 2018 Dec 17.

2.

The Chemical Molecule B355252 is Neuroprotective in an In Vitro Model of Parkinson's Disease.

Gliyazova NS, Ibeanu GC.

Cell Mol Neurobiol. 2016 Oct;36(7):1109-22. doi: 10.1007/s10571-015-0304-5. Epub 2015 Dec 9.

PMID:
26649727
3.

Transcriptional Response of Selenopolypeptide Genes and Selenocysteine Biosynthesis Machinery Genes in Escherichia coli during Selenite Reduction.

Tetteh AY, Sun KH, Hung CY, Kittur FS, Ibeanu GC, Williams D, Xie J.

Int J Microbiol. 2014;2014:394835. doi: 10.1155/2014/394835. Epub 2014 Apr 15.

4.

A novel phenoxy thiophene sulphonamide molecule protects against glutamate evoked oxidative injury in a neuronal cell model.

Gliyazova NS, Huh EY, Ibeanu GC.

BMC Neurosci. 2013 Sep 2;14:93. doi: 10.1186/1471-2202-14-93.

5.

A rapid, inexpensive high throughput screen method for neurite outgrowth.

Yeyeodu ST, Witherspoon SM, Gilyazova N, Ibeanu GC.

Curr Chem Genomics. 2010 Dec 13;4:74-83. doi: 10.2174/1875397301004010074.

6.

A synthetic analog of verbenachalcone potentiates NGF-induced neurite outgrowth and enhances cell survival in neuronal cell models.

Clement CM, Dandepally SR, Williams AL, Ibeanu GC.

Neurosci Lett. 2009 Aug 14;459(3):157-61. doi: 10.1016/j.neulet.2009.05.010. Epub 2009 May 7.

7.

A high throughput fluorescence polarization assay for inhibitors of the GoLoco motif/G-alpha interaction.

Kimple AJ, Yasgar A, Hughes M, Jadhav A, Willard FS, Muller RE, Austin CP, Inglese J, Ibeanu GC, Siderovski DP, Simeonov A.

Comb Chem High Throughput Screen. 2008 Jun;11(5):396-409.

8.

A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin.

Ibeanu GC, Blaisdell J, Ferguson RJ, Ghanayem BI, Brosen K, Benhamou S, Bouchardy C, Wilkinson GR, Dayer P, Goldstein JA.

J Pharmacol Exp Ther. 1999 Aug;290(2):635-40.

PMID:
10411572
9.

An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians.

Ibeanu GC, Blaisdell J, Ghanayem BI, Beyeler C, Benhamou S, Bouchardy C, Wilkinson GR, Dayer P, Daly AK, Goldstein JA.

Pharmacogenetics. 1998 Apr;8(2):129-35.

PMID:
10022751
10.

Identification of residues 286 and 289 as critical for conferring substrate specificity of human CYP2C9 for diclofenac and ibuprofen.

Klose TS, Ibeanu GC, Ghanayem BI, Pedersen LG, Li L, Hall SD, Goldstein JA.

Arch Biochem Biophys. 1998 Sep 15;357(2):240-8.

PMID:
9735164
11.

Identification of new human CYP2C19 alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian poor metabolizer of mephenytoin.

Ibeanu GC, Goldstein JA, Meyer U, Benhamou S, Bouchardy C, Dayer P, Ghanayem BI, Blaisdell J.

J Pharmacol Exp Ther. 1998 Sep;286(3):1490-5.

PMID:
9732415
12.

Identification of residues 99, 220, and 221 of human cytochrome P450 2C19 as key determinants of omeprazole activity.

Ibeanu GC, Ghanayem BI, Linko P, Li L, Pederson LG, Goldstein JA.

J Biol Chem. 1996 May 24;271(21):12496-501.

13.
14.

Structural organization of the mouse DNA repair gene, N-methylpurine-DNA glycosylase.

Tatsuka M, Ibeanu GC, Izumi T, Narayan S, Ramana CV, Kim NK, Kang W, Roy G, Mitra S.

DNA Cell Biol. 1995 Jan;14(1):37-45.

PMID:
7832991
15.
16.

Molecular cloning of Clostridium difficile toxin A gene fragment in lambda gt11.

Muldrow LL, Ibeanu GC, Lee NI, Bose NK, Johnson J.

FEBS Lett. 1987 Mar 23;213(2):249-53.

Supplemental Content

Loading ...
Support Center